LoginSignup
JNJ

Johnson & Johnson CEDEAR

Stock
Stock
ISIN: ARDEUT110236
Ticker: JNJ3
ARDEUT110236
JNJ3

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Johnson & Johnson CEDEAR has so far distributed $0.00006193 in 2026. The next dividend will be paid on 10.06.2026

$0.001357

CHART BY

Frequently asked questions

What is Johnson & Johnson CEDEAR's market capitalization?

The market capitalization of Johnson & Johnson CEDEAR is $807.82T. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Johnson & Johnson CEDEAR's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Johnson & Johnson CEDEAR is 29.19. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Johnson & Johnson CEDEAR?

Johnson & Johnson CEDEAR's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $766.45. EPS indicates the company's profitability on a per-share basis.

What is Johnson & Johnson CEDEAR's revenue over the trailing twelve months?

Over the trailing twelve months, Johnson & Johnson CEDEAR reported a revenue of $128.57T.

What is the EBITDA for Johnson & Johnson CEDEAR?

Johnson & Johnson CEDEAR's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $44.68T. EBITDA measures the company's overall financial performance.

What is the free cash flow of Johnson & Johnson CEDEAR?

Johnson & Johnson CEDEAR has a free cash flow of $22.77T. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Johnson & Johnson CEDEAR have, and what sector and industry does it belong to?

Johnson & Johnson CEDEAR employs approximately 140,800 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.

Financials

Market Cap 
$807.82T
EPS (TTM) 
$766.45
P/E ratio (TTM) 
29.19
Revenue (TTM) 
$128.57T
EBITDA (TTM) 
$44.68T
Free Cashflow (TTM) 
$22.77T

Pricing

52W span
$9.902$17.75

Information

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Employees
140,800
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

ISIN
ARDEUT110236
Primary Ticker
JNJ3
Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin